Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.
Publication
, Journal Article
Yang, C; Xie, M; Zhang, K; Liu, H; Liang, A; Young, KH; Qian, W
Published in: Leukemia
November 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Leukemia
DOI
EISSN
1476-5551
Publication Date
November 2020
Volume
34
Issue
11
Start / End Page
3055 / 3059
Location
England
Related Subject Headings
- Virus Activation
- Viral Load
- Lymphoma, Large B-Cell, Diffuse
- Immunotherapy, Adoptive
- Immunosuppressive Agents
- Immunology
- Humans
- Hepatitis B, Chronic
- Hepatitis B virus
- Antigens, CD19
Citation
APA
Chicago
ICMJE
MLA
NLM
Yang, C., Xie, M., Zhang, K., Liu, H., Liang, A., Young, K. H., & Qian, W. (2020). Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection. Leukemia, 34(11), 3055–3059. https://doi.org/10.1038/s41375-020-0913-y
Yang, Chunmei, Mixue Xie, Kaifeng Zhang, Hui Liu, Aibin Liang, Ken H. Young, and Wenbin Qian. “Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.” Leukemia 34, no. 11 (November 2020): 3055–59. https://doi.org/10.1038/s41375-020-0913-y.
Yang C, Xie M, Zhang K, Liu H, Liang A, Young KH, et al. Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection. Leukemia. 2020 Nov;34(11):3055–9.
Yang, Chunmei, et al. “Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.” Leukemia, vol. 34, no. 11, Nov. 2020, pp. 3055–59. Pubmed, doi:10.1038/s41375-020-0913-y.
Yang C, Xie M, Zhang K, Liu H, Liang A, Young KH, Qian W. Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection. Leukemia. 2020 Nov;34(11):3055–3059.
Published In
Leukemia
DOI
EISSN
1476-5551
Publication Date
November 2020
Volume
34
Issue
11
Start / End Page
3055 / 3059
Location
England
Related Subject Headings
- Virus Activation
- Viral Load
- Lymphoma, Large B-Cell, Diffuse
- Immunotherapy, Adoptive
- Immunosuppressive Agents
- Immunology
- Humans
- Hepatitis B, Chronic
- Hepatitis B virus
- Antigens, CD19